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Abstract 
Backgrounds: Crohn’s disease (CD) patients with small bowel strictures are at risk of 
surgery. Double-balloon enteroscopy (DBE) can evaluate the status of the small intestine, 
and retrograde contrast through the scope enables the surgeon to obtain information 
beyond the reach of the scope. This study aimed to examine whether a retrograde contrast 
study through DBE could be used as a predictor of subsequent surgery in CD patients with 
small intestinal strictures. 
Methods: The findings of DBE with retrograde contrast in 48 CD patients with small 
bowel strictures were examined.  
Results: Of the 48 patients, 14 (29%) underwent surgery for small intestinal strictures 
during a median observation period of 2.4 years (interquartile range: 1.4–3.7 years). 
According to the results of the multivariate analysis, a maximum length of strictures ≥ 20 
mm and the ratio of the maximum diameter of prestenotic dilations to the diameter of the 
normal small intestine ≥ 1.4 were independent risk factors of surgery for small intestinal 
strictures (risk ratio = 7.6 [95% CI: 1.8-42.0], p = 0.006; and risk ratio = 52.0 [95% CI: 
3.5-2485.1], p = 0.002, respectively). The latter predicted subsequent surgery with 92% 
sensitivity and 88% specificity. Cumulative surgery-free rates were discriminated 
significantly according to the presence or absence of these two risk factors (log-rank test: 
p < 0.001) 
Conclusions: Findings of retrograde contrast through DBE are helpful to predict risk of 
surgery in CD patients with small intestinal strictures. 
Keywords: Crohn’s disease, double-balloon enteroscopy, retrograde contrast  
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Introduction 
Crohn’s disease (CD) is a chronic inflammatory disease of the gastrointestinal 
tract that can involve the entire gastrointestinal tract and causes several complications, 
including intestinal and extra-intestinal disease.
1-3
 Intestinal stricture is one of the most 
common intestinal complications in patients with CD, and it can reduce their quality of 
life because of symptoms of stenosis, which often necessitates surgery.
4, 5
 Strictures occur 
in the small intestine more frequently than in the colon possibly due to its narrow diameter. 
Repetitive surgical interventions for recurrent strictures in the small intestine can lead to 
intestinal failure and malnutrition.
6
 Despite recent advances in medical therapy and 
endoscopic balloon dilation, up to 30% of patients require at least one surgical resection 
within 10 years after diagnosis.
7
 In this regard, accurate evaluation of small intestinal 
lesions and adequate assessment of risk for surgery are mandatory in clinical practice.   
Although imaging modalities, including computed tomography (CT) 
enterography, magnetic resonance (MR) enterography and transabdominal ultrasound are 
useful for evaluation of small bowel status, the findings associated with the risk of surgery 
are rarely reported. Recent reports have demonstrated that MR imaging could detect 
critical strictures, and that detection of stenosis with the modality was a predictive factor 
for surgery.
8, 9
 However, the positive predictive value (PPV) of stenosis detection with MR 
for surgery was low (less than 30%), indicating that the modality could not sufficiently 
predict the risk of surgery.   
 Double-balloon enteroscopy (DBE) has become common in recent decades and 
the usefulness for assessment of the small bowel has been reported.
10
 DBE has unique 
advantages, in that histopathologic specimens can be obtained and performing therapeutic 
procedures such as balloon dilation for strictures is possible, in addition to reaching and 
observing the deep small intestine. However, DBE is a time and energy-consuming 
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procedure. Additionally, accessing the deep small intestine is difficult, particularly in 
patients with multiple surgeries, severe intra-abdominal adhesions, or strictures. When 
deep insertion into the small intestine is not allowed, information regarding the small 
intestine beyond the reach of the scope could be obtained by introducing retrograde 
contrast through the DBE scope. The procedure can be easily performed by injection of 
water-soluble contrast medium without additional operations or further equipment. 
However, the clinical relevance of retrograde contrast findings in CD patients has not been 
fully reported.  
We hypothesized that retrograde contrast findings during DBE could predict the 
risk of surgery in CD patients. The aim of this study was to examine which findings of the 
retrograde contrast could be used as predictors of subsequent surgery in CD patients with 
small intestinal strictures.  
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Materials and Methods 
Patients 
Eighty-seven consecutive patients with CD who underwent DBE with retrograde 
contrast for evaluation of small intestinal status at Okayama University Hospital from 
March 2009 to May 2015 were considered eligible for this retrospective study. Of the 87 
patients, a patient who was lost to follow-up, a patient who underwent surgery for perianal 
abscess, and a patient with incomplete retrograde contrast because of the stricture being 
too severe were excluded. In addition, 36 patients who had no strictures in the small 
intestine were excluded. Consequently, a total of 48 patients with stenosis in the small 
bowel were evaluated in the present study. Data regarding medical history, clinical 
findings, and findings of the retrograde contrast were obtained from electrical medical 
records of the hospital. 
Patients were followed-up until the time of surgery associated with the small 
bowel strictures or until May 2016. The risk factors that affected the bowel resection after 
retrograde contrast were identified. In addition, the cumulative surgery-free rates were 
calculated according to the presence or absence of risk factors.  
 
Procedure of retrograde contrast under DBE 
Retrograde contrast was carried out using the double-balloon enteroscope 
EN-450T5
®
 (Fujifilm, Tokyo, Japan) with the DBE system by experienced endoscopists 
(S.K. and T.I). Carbon dioxide insufflation was employed during DBE and retrograde 
contrast.
11
 The DBE scope was inserted into the proximal small intestine as far as the 
scope could reach using a retrograde approach, and the contrast study through the scope 
was performed after inflating the balloon at the distal end of the scope for prevention of 
backflow of the contrast medium. If necessary and possible, during the scope insertion, 
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DBE-assisted balloon dilation was performed for the small intestine strictures through 
which the scope could not pass, after assessing the characteristics of the stricture with 
retrograde contrast. 
During the retrograde contrast, 200 mL of double-diluted meglumine diatrizoate
®
 
(Bayer, Leverkusen, Germany), a water-soluble contrast medium, was used. After filling 
the contrast medium, an appropriate amount of carbon dioxide gas was insufflated to gain 
the double-contrast figures of the small intestine until the Treitz ligament. To facilitate 
regurgitation of the medium, abdominal compression and change in body position were 
applied as appropriate. With these maneuvers, full inspection of the small bowel could be 
achieved for all subjects.  
 
Definitions of parameters on the retrograde contrast  
Within the reach of the enteroscope, a stricture was defined as the lesion through 
which the scope could not pass without balloon dilation. Beyond the reach of the scope, 
the lesion with a diameter less than 50% of the “normal” was counted as a stricture. 
Because the “normal” diameter of the small intestine varies widely among individuals, it 
was determined in each patient by measurement of the diameter of the small intestinal 
portion where the following criteria were fulfilled: procurement of definite retrograde 
contrast images (approximately within 50 cm of the stricture at the oral side), no evidence 
of inflammation, ulcers, and curing findings, and appearance of uniform Kerckring’s folds. 
A maximum diameter of prestenotic dilation was defined as the most extended diameter 
located immediately at the oral side of the stricture. Stricture lengths were measured in all 
detected stenosis regardless of within or beyond the reach of the scope, based on 
retrograde contrast images.  
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According to DBE findings and retrograde contrast, following parameters were 
used for analysis: the number of strictures, minimum diameter of strictures, maximum 
length of strictures, maximum diameter of prestenotic dilations (M), and diameter of the 
normal small intestine (N; Figure 1). Additionally, the ratio of the maximum diameter to 
the diameter of the normal small intestine (M/N ratio) was calculated. These 
measurements were retrospectively performed by experienced endoscopists (N.O., and 
S.H.) based on the computerized film database, with the results of prognosis being 
blinded.  
 
Statistical analysis 
Patient characteristics and parameters based on DBE findings and retrograde 
contrast were compared using Fisher’s exact test or Wilcoxon rank-sum test, as 
appropriate. Optimal cutoff values for continuous variables were determined using 
receiver operating characteristic (ROC) curve analysis, and sensitivity, specificity, PPV, 
negative predictive value (NPV), accuracy, and area under the curve (AUC) for 
subsequent surgery were calculated. In addition, the risk of bowel resection was assessed 
using Cox regression analysis with those parameters. Variables with a p-value below 0.05 
in a univariate analysis were further tested in a multivariate analysis, and the risk ratios 
with 95% confidence intervals (CIs) were calculated. Survival analyses for the time 
without bowel resection were carried out using Kaplan-Meier method. Statistical 
comparison was carried out by log-rank test. A p-value < 0.05 was considered statistically 
significant. All statistical analyses were performed using JMP ver.12 pro software (SAS 
Institute, Cary, NC, USA). 
 
Ethical considerations 
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This study was approved by the institutional review board of Okayama 
University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences. There 
were no conflicts of interest or sponsors of this study.   
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Results 
Patient characteristics 
DBE with or without balloon dilation, and retrograde contrast were performed 
safely for all subjects who underwent these procedures, and no adverse events including 
perforation and bleeding were observed. A total of 48 patients who showed small intestinal 
strictures with the DBE and retrograde contrast were examined. Patient characteristics are 
shown in Table 1. The median observation period after the retrograde contrast was 2.4 
years (interquartile range (IQR): 1.4–3.7 years). Of these, 14 patients underwent surgery 
for small intestinal strictures, while the remaining 34 did not. The ratio of smokers was 
higher in patients with bowel resection (43% vs. 9%, p = 0.01). Thiopurine or 
corticosteroid use was less frequently observed in patients with bowel resection (7% vs. 
50%, p = 0.003, and 0% vs. 21%, p = 0.02, respectively). Balloon dilation was performed 
for 25 patients (6 (43%) vs. 19 (56%), p = 0.53), with one to three dilatations for each 
patient (total 31 dilatations). 
 
Findings of retrograde contrast through the DBE scope 
The retrograde contrast findings of the patients with and without surgery are 
shown in Table 2. There were significant differences in number of strictures (4 vs. 1, p < 
0.0001), minimum diameter of strictures (4 mm vs. 6 mm, p = 0.007), maximum length of 
strictures (21 mm vs. 13 mm, p = 0.003), maximum diameter of prestenotic dilations (43 
mm vs. 31 mm, p = 0.005), and M/N ratio (1.61 vs. 1.22, p < 0.0001) between patients 
with and without surgery for small intestinal strictures. 
 
Sensitivity, specificity, and predictive values of the retrograde contrast findings for 
bowel resections 
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The sensitivity, specificity, PPV, NPV, accuracy, and AUC of each parameter 
showing statistical significance for bowel resection are shown in Table 3. According to the 
AUC, M/N ratio was the best associated with subsequent surgery for small intestinal 
strictures.  
 
The univariate and multivariate analysis of variables associated with bowel resection  
The univariate and multivariate analyses of risk factors for bowel resection were 
performed using Cox regression analysis (Table 4). According to the results of the 
multivariate analysis, maximum length of strictures of ≥ 20 mm and M/N ratio of ≥ 1.4 
were independent risk factors of surgery for small intestinal strictures (risk ratio = 7.6 
[95% CI: 1.8-42.0], p = 0.006; and risk ratio = 52.0 [95% CI: 3.5-2485.1], p = 0.002, 
respectively). The diagnostic ability of the combination of these two parameters showed 
the lower AUC (0.79), with lower sensitivity and NPV (57.1% and 85%, respectively) and 
the best specificity and PPV (100% each). 
 
Cumulative surgery-free rate of CD patients with small intestinal strictures  
Cumulative surgery-free rate of the 48 subjects with small intestinal strictures 
was 76.4%, 73.6%, and 70.2% at 1, 2, and 3 years after the DBE procedure, respectively 
(Figure 2A). Surgery-free rates according to the presence or absence of the two significant 
risk factors differ significantly (p < 0.001, log-rank test; Figure 2B). The one-year 
surgery-free rates of subjects with no risk factors, one risk factor, and two risk factors 
were 100%, 78.9%, and 12.5%, respectively.   
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Discussion 
A number of clinical and genetic factors have been reported to be associated with 
the development of strictures in patients with CD, including ileocolonic disease location, 
long disease duration, severe disease, and NOD2/CARD15 mutations.
8, 12
 As risk factors 
for surgery, Solberg et al. identified terminal ileal location, stricturing or penetrating 
behavior, and age younger than 40 years at diagnosis.
13
 Evaluation using DBE revealed 
that presence of fistula was significantly associated with the need for surgery as a 
long-term clinical outcome of strictures in CD patients.
14
 Smoking was also shown to be a 
risk for endoscopic re-dilation or sugery.
15, 16
 Moreover, a recent work demonstrated that 
detection of stenosis with MR enterography was a risk of surgery for small intestinal 
stenosis.
9
  
Despite these previous reports, attempts for evaluation of surgical risk for small 
intestinal lesions by using imaging modalities have been scarce. In this study, we 
demonstrated that the findings of retrograde contrast using DBE could predict the risk of 
small bowel resection for strictures in CD patients. In particular, a maximum length of 
strictures ≥ 20 mm and an M/N ratio ≥ 1.4 proved to be significant risk factors for bowel 
resection in those patients. 
Lesions in the small intestine can lead to intestinal complications, including 
stenosis and fistula more easily than colorectal lesions in CD patients, possibly due to the 
smaller caliber of the small intestine. Nevertheless, accurate evaluation of small intestinal 
lesions has been challenging because of its length and deep anatomic location, in contrast 
to the relative ease of inspection of the colorectum using colonoscopy. In recent years, 
several modalities, including CT or MR enterography, and video capsule endoscopy 
(VCE), have been developed, and the usefulness of these procedures in the evaluation of 
small intestinal lesions of CD have been reported.
17-19
 However, the performance of these 
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methods has not always been satisfactory. Additionally, these modalities have limitations 
to their clinical use: requirement of specialized facilities and expert radiologists, risk of 
radiation exposure in CT, and risk of retention of VCE. Our methodology of DBE with 
retrograde contrast has the following advantages over those other modalities: the higher 
sensitivity for detection of strictures compared to MRI,
17
 accurate measurement of each 
parameter associated with stricture because of direct injection of contrast medium at the 
closest position from stenosis, minimum risk of ileus because of retrograde injection of 
contrast medium, and feasibility of balloon dilatation for the narrowest strictures.  
DBE is an effective method for assessment of small bowel lesions in patients 
with CD that allows observation of deep small bowel lesions where colonoscopy cannot 
reach.
20
 In fact, it has been shown that findings of DBE were correlated with fecal 
calprotectin levels more precisely than those of ileocolonoscopy, suggesting that DBE 
yields a more accurate evaluation of inflammation in the small bowel.
21-23
 In addition, 
DBE enabled not only direct observation of the mucosal status but also biopsies or other 
treatment procedures if needed. However, DBE sometimes cannot access the deep small 
intestine in cases with history of multiple surgeries, severe intra-abdominal adhesions 
and/or strictures, all of which occur frequently in CD patients.  
Retrograde contrast study, which was applied in this report, can partly overcome 
such shortcomings of DBE. The procedure could be achieved relatively easily, by 
injecting water-soluble medium and air through the scope channel after just inflating the 
balloon at the distal end of the scope. Although it could provide detailed information of 
the portion of the small intestine where DBE scope could not reach, the clinical relevance 
of findings of this procedure has scarcely been reported.  
In our study with retrograde contrast, two risk factors associated with strictures 
for small bowel resections were identified; the length of strictures and the diameters of 
Okazaki et al. 13 
prestenotic dilations. First, long strictures have been shown to be a risk factor for surgical 
resections in CD patients. A previous report showing the prognosis of CD patients who 
underwent balloon dilation demonstrated that strictures were significantly longer in 
patients who received surgery after balloon dilation than in patients without surgery (7.5 
cm vs. 2.5 cm, p = 0.006).
24
 In this regard, Sunada et al precluded strictures that exceeded 
50 mm in length from the indication of balloon dilation,
14
 and others advocated that 
candidate lesions of balloon dilation were less than 4 cm with regard to potential 
efficacy.
25, 26
 Hence, our criterion of 20 mm or longer strictures may appear to be too short 
to give up balloon dilation. However, most of those existing reports included colonic 
lesions evaluated with colonoscopy alone, and reports showing indications and outcomes 
of balloon dilation for strictures in the small intestine alone have been scarce.
24, 27, 28
 
Definite imaging of strictures in the deep small bowel that DBE cannot reach is 
responsible for determination of the short criterion of our study. In fact, a recent study 
indicated that shorter detection limit of small bowel stenosis with MR imaging (10 mm) is 
one of the criteria for higher risk of surgery.
9
 Thus, the length of the small bowel stricture 
that could be treated using balloon dilation alone appears to be shorter than previously 
considered.  
Prestenotic dilation, another risk factor identified in this study, is thought to occur 
due to chronic dysfunction of intestinal mobility. In fact, bowel stenosis with prestenotic 
dilation was more closely correlated with secondary loss of response to anti-tumor 
necrosis factor antibodies than bowel stenosis without prestenotic dilation.
29
 However, the 
relationship between the degree of prestenotic dilation and risk of surgery has scarcely 
been reported, maybe because accurate evaluation of prestenotic dilation is difficult due to 
variability of normal diameters of the small intestine. The M/N ratio defined in the current 
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study may be ideal to evaluate prestenotic dilation, and having identified it as one of the 
risks of surgery would be very helpful in clinical practice.  
Meanwhile, minimum diameter of strictures and the number of strictures were not 
identified as the risk of surgery. This suggests that even the narrowest stenosis and 
multiple strictures in the small intestine could be overcome by balloon dilation with DBE 
if the length of the stenosis is sufficiently short. Thus, balloon dilation for the small bowel 
stricture by using DBE appears to be a clinically useful procedure to avoid surgery, 
although the procedure requires specific techniques and skills. Furthermore, as an 
additional negative result of this study, it should be of note that obstructive symptoms are 
not always reliable when estimating the degree of the strictures.    
The differentiation between inflammatory and fibrotic stenosis has been 
considered critical because medical treatments are indicated for inflammation, whereas 
fibrosis requires mechanical treatments including endoscopic balloon dilation or surgery.
30, 
31
 In fact, Holtmann et al reported that fibrotic strictures are unlikely to respond to 
anti-inflammatory medical treatment.
32
 In this regard, our two criteria, maximum length of 
strictures ≥ 20 mm and an M/N ratio ≥ 1.4, may reflect fibrotic strictures. To verify this 
concept, further studies are required in the future. 
This study has limitations that are common to retrospective studies performed in 
a single center. The number of evaluated patients was small. Because of these limitations, 
multivariate analysis was not reliable enough with wide 95% CIs even in variables with 
statistical significance. However, the surgery-free rate of our patients (76% at one year) 
was equivalent to reported surgery-free rates after DBE-assisted balloon dilation (60% - 
87.3% at 1 year),
14, 20, 33, 34
 indicating that our study was reasonable and conducted 
appropriately. In this regard, our results should be validated in a prospective manner in the 
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future. Lastly, the results might be more reliable if the findings of retrograde contrast had 
been compared with other imaging modalities. 
In conclusion, the present study showed that findings of retrograde contrast 
through DBE could identify small intestinal strictures with high risk of surgery. In 
particular, patients who showed strictures with a length of 20 mm or more and prestenotic 
dilation with this modality are at extremely high risk for bowel resection and should be 
considered to undergo surgery without performing balloon dilation.  
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 Figure Legends 
Figure 1. Retrograde contrast through DBE and schematic diagram of evaluated 
parameters. 
(A) Minimum diameter of stricture, (B) maximum length of stricture, (M) maximum 
diameter of prestenotic dilation, and (N) diameter of normal small intestine with 
retrograde contrast were measured in each case. White dashed-circle indicated the 
inflated balloon at the end of the scope. 
 
 
Figure 2. Kaplan-Meier analysis of cumulative surgery-free rates of the patients 
(A) Cumulative surgery-free rate of all the 48 patients with small intestinal 
strictures.  
Cumulative surgery-free rates of all the subjects were 76.4%, 73.6%, and 70.2% at 1, 2, 
and 3 years after the DBE procedure, respectively. 
 
(B) Cumulative surgery-free rates according to the presence or absence of 
significant risk factors identified by multivariate analysis.  
Surgery-free rates of subjects with no risk factor, one risk factor, and two risk factors 
differed significantly, and one-year surgery free-rates of those subjects were 100%, 
78.9%, and 12.5%, respectively. 
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Table 1. Clinical characteristics of the study population.  
Patients (n = 48) 
CD patients with 
bowel resection 
CD patients without 
bowel resection p-value 
 (n = 14)  (n = 34) 
Gender (Male / Female) 11 / 3 19 / 15 0.20 
Age (years) * 36 (29-41) 39 (33-44) 0.42 
Age at diagnosis (years) * 24 (22-35) 30 (24-39) 0.29 
Duration of disease (years) * 6.7 (3.1-12.6) 5.6 (0.2-11.2) 0.68 
Disease location 
   
  L1: ileal / L3: ileocolonic 6 (43%) / 8 (57%) 22 (65%) / 12 (35%) 0.21 
Disease behavior 
   
  B2: structuring / B3: penetrating 9 (64%) / 5 (36%) 25 (74%) / 9 (26%) 0.20 
Perianal disease 6 (43%) 15 (44%) 1.00 
Smoking  6 (43%) 3 (9%) 0.012 
History of surgery  6 (43%) 16 (47%) 1.00 
Obstructive symptoms 11 (79%) 16 (47%) 0.059 
Endoscopic balloon dilation 6 (43%) 19 (56%) 0.53 
Medications  
   
  5-aminosalycylic acid  13 (93%) 31 (91%) 0.85 
  Elemental diet  10 (71%) 27 (79%) 0.56 
  Thiopurine  1 (7%) 17 (50%) 0.0025 
  Corticosteroids  0 (0%) 7 (21%) 0.021 
  TNF-alpha antagonist  5 (36%) 18 (53%) 0.27 
Blood examinations 
   
  White blood cells (/mm3) * 5000 (4213-6453) 5080 (4080-6450) 0.90 
  Hemoglobin (g/dL) * 13.6 (12.8-14.7) 12.6 (11.7-13.8) 0.11 
  Albumin (g/dL) * 4 (3.6-4.4) 3.9 (3.5-4.3) 0.93 
  C-reactive protein (mg/dL) * 0.24 (0.14-0.98) 0.15 (0.04-0.30) 0.10 
*median (IQR)  
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Table 2. Comparison of the findings of retrograde contrast through DBE between CD 
patients with and without bowel resection. 
 
The findings of retrograde contrast 
CD patients with 
bowel resection 
CD patients without 
bowel resection p-value 
(n = 14) (n = 34) 
Number of strictures* 4 (3-5) 1 (1-5) < 0.0001 
Minimum diameter of strictures (mm)* 4 (3-4) 6 (3-9) 0.007 
Maximum length of strictures (mm)* 21 (16-27) 13 (4-50) 0.003 
Maximum diameter of prestenotic dilation (mm)* 43 (34-47) 31 (22-56) 0.005 
Diameter of normal small intestine (mm)* 24 (22-27) 26 (24-28) 0.20 
M/N ratio* 1.6 (1.5-1.7) 1.2 (1.1-1.3) < 0.0001 
*median (IQR) 
M, maximum diameter of prestenotic dilation 
N, normal diameter of small bowel   
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Table 3.  Sensitivity, specificity, predictive values and AUC for bowel resection.  
 
  
Number of 
strictures 
 (≥ 3) 
Minimum 
diameter of 
strictures 
 (≤ 5 mm) 
Maximum 
length  
of strictures  
(≥ 20 mm) 
M (≥ 42 mm) M/N (≥ 1.4) 
Sensitivity (%) 85.7 92.9 64.3 57.1 92.9 
Specificity (%) 73.5 55.9 73.5 88.2 88.2 
PPV (%) 57.1 46.4 50.0 66.7 76.5 
NPV (%) 92.6 95.0 83.3 83.3 96.8 
Accuracy (%) 77.1 58.3 70.8 79.2 89.6 
AUC 0.85 0.75 0.78 0.76 0.91 
M, maximum diameter of prestenotic dilation 
N, normal diameter of small bowel 
PPV, positive predictive value 
NPV, negative predictive value  
AUC, area under the receiver operating characteristic curve  
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Table 4.  Univariate and multivariate analysis of variables associated with bowel 
resection using Cox regression model.  
 
Risk factors 
Univariate Multivariate 
Risk ratio (95% CI) p-value Risk ratio (95% CI) p-value 
Smoking  4.7 (1.5-13.6) 0.009 0.4 (0.09-1.5) 0.16 
Obstructive symptoms  3.3 (1.1-14.8) 0.04 0.3 (0.05-2.1) 0.23 
Medications during the study periods 
    
 Thiopurine (no) 11.1 (2.2-201.9) 0.001 2.3 (0.2-54.1) 0.48 
Retrograde contrasting 
    
 Number of strictures (≥ 3) 10.4 (2.8-67.2) 0.0001 1.6 (0.3-11.5) 0.60 
 Minimum diameter of strictures (≤ 5 mm) 11.7 (2.3-210.7) 0.001 1.3 (0.1-30.7) 0.85 
 Maximum length of strictures (≥ 20 mm) 3.7 (1.3-12.2) 0.02 7.6 (1.8-42.0) 0.006 
 M/N ratio (≥ 1.4) 40.8 (8.0-744.7) < 0.0001 52.0 (3.5-2485.1) 0.002 
CI, confidence interval 
M, maximum diameter of prestenotic dilation 
N, normal diameter of small bowel 
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